Business Context and Reporting Period
This Form 6-K filing by Xiaobai Maimai Inc. (not Akso Health Group) covers the month of July 2021, with a report date of July 15, 2021. The filing discloses a change in the composition of the Board of Directors and executive management.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure regarding corporate governance rather than a financial performance report.
Material Changes
- Resignation: On July 14, 2021, Ms. Luping Wei resigned from her positions as a Director and Vice President of Operations. The resignation was not due to any disagreement with the Company.
- Appointment: On the same date, Ms. Wenjuan (Vivian) Liu was appointed as a Director to fill the vacancy created by Ms. Wei's resignation, effective immediately.
- Compensation: Ms. Liu's annual compensation is set at $240,000 pursuant to a Director Offer Letter.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies related to financial operations are disclosed in this document. The appointment of Ms. Liu is noted to have no material interest conflicts or family relationships with existing officers.
Key Facts for Investor Verification
- Verify the exact legal name of the registrant is Xiaobai Maimai Inc., distinct from the "Akso Health Group" mentioned in the request metadata.
- Confirm the effective date of the Board change was July 14, 2021.
- Note the annual compensation of $240,000 for the newly appointed Director, Ms. Wenjuan (Vivian) Liu.
- Review the attached Exhibit 99.1 (Director Offer Letter) for full terms of the appointment.